Staying in
the know

We are committed to developing safe and effective therapies to help transform realities for those living with rare disease. But that also means helping you stay current and up to date on what is going on today. Learn more about resources that are available to provide support to you and your family.

to genetic

Mirum sponsors a genetic cholestasis panel testing at no cost to patients
to help accurately identify a variety of conditions. This panel may
assist in diagnosing a cholestatic liver disease.

ALGS Vitamins and Supplements Fund

Patients with Alagille syndrome (ALGS) often experience a reduced flow of bile to the small intestine which can cause problems digesting fats and absorbing fat-soluble vitamins such as vitamins A, D, E, and K. These deficiencies may cause malnutrition and contribute to complications related to growth. As such, vitamins often become an essential component to care for children with ALGS.

The HealthWell Foundation, a US-based organization, has launched a new fund to provide financial assistance to patients living in the U.S. with ALGS. Through the fund, eligible patients within the U.S. and U.S. territories who have annual household incomes up to 500 percent of the federal poverty level can qualify for up to $1,500 in financial assistance to obtain vitamins and supplements for the management of their condition.

Support for living with a rare disease

Find support for people and families living with rare disease:

Information about Alagille syndrome (ALGS)
Information about progressive familial
intrahepatic cholestasis (PFIC)
Information about primary sclerosing cholangitis (PSC)
Information about primary biliary
cholangitis (PBC)
Information about Peroxisome Biogenesis Disorder – Zellweger Spectrum Disorder (PBD-ZSD)
Information about Cerebrotendinous Xanthomatosis (CTX)
Information about Smith-Lemli-Opitz Syndrome (SLOS)

LIVMARLI® (maralixibat)
oral solution

Mirum’s Expanded Access Program (EAP) offers access to
LIVMARLI (maralixibat) for eligible patients with ALGS and PFIC.

Accessing Mirum Medicines

LIVMARLI (maralixibat)

Mirum Access Plus (MAP) – U.S.

Designed to help patients and families start and stay on
LIVMARLI (maralixibat), this program connects patients and
families with MAP experts who can help educate on the
journey, from treatment access to financial support.

Embrace Patient Support Program – Canada

Designed to help patients and families navigate the LIVMARLI
treatment journey, the program connects patients and their
families with experts who can help explain the process of
getting medication, work with healthcare teams to determine
insurance coverage and confirm eligibility for financial
support programs.

For more information, call 1-833-505-1242 or email

Cholbam (cholic acid)

Total Care HUB – U.S.

Total Care HUB will continue to service patients while
transitioning to Mirum Access Plus (MAP). Total Care
HUB is designed to help patients and families navigate
the treatment journey by providing support in the
following ways:
  • Explain the process of getting medication
  • Work with dedicated healthcare teams to figure out insurance coverage and eligibility for financial support programs
  • Provide education and resources to help patients start and stay on therapy

Chenodal (Chenodiol Tablets) 250 mg

Total Care HUB – U.S.

Total Care HUB will continue to service patients while transitioning
to Mirum Access Plus (MAP). Total Care HUB is the exclusive
pharmacy for Chenodal.

For more information, call 844-246-5226

Total Care HUB is a registered
trademark and transitional
of Travere Therapeutics, Inc